{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:19:19Z","timestamp":1792189159186,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T00:00:00Z","timestamp":1662681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Mycology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.mycmed.2022.101330","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T12:01:39Z","timestamp":1662638499000},"page":"101330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Clinical characteristics and risk factors of in-hospital mortality in patients coinfected with Pneumocystis jirovecii and Aspergillus"],"prefix":"10.1016","volume":"33","author":[{"given":"Yuxia","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4460-491X","authenticated-orcid":false,"given":"Deyun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mycmed.2022.101330_bib0001","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1007\/s40261-012-0019-z","article-title":"Clinical experience in invasive fungal infections: multiple fungal infection as the first presentation of HIV","volume":"33","author":"Mihon","year":"2013","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.mycmed.2022.101330_bib0002","doi-asserted-by":"crossref","first-page":"i39","DOI":"10.1093\/jac\/dkx032","article-title":"Invasive mould infections in the ICU setting: complexities and solutions","volume":"72","author":"Bassetti","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2022.101330_bib0003","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/myc.12642","article-title":"Pulmonary co-infections by Pneumocystis jirovecii and Aspergillus fumigatus in non-HIV patients: a report of two cases and literature review","volume":"60","author":"Markantonatou","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2022.101330_bib0004","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2022.101330_bib0005","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa1503326","article-title":"High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure","volume":"372","author":"Frat","year":"2015","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.mycmed.2022.101330_bib0006","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.3390\/ijerph17165994","article-title":"High-flow oxygen through nasal cannula vs. non-invasive ventilation in hypercapnic respiratory failure: a randomized clinical trial","volume":"17","author":"Papachatzakis","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.mycmed.2022.101330_bib0007","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/thoraxjnl-2019-213303","article-title":"Home initiation of chronic non-invasive ventilation in COPD patients with chronic hypercapnic respiratory failure: a randomised controlled trial","volume":"75","author":"Duiverman","year":"2020","journal-title":"Thorax"},{"key":"10.1016\/j.mycmed.2022.101330_bib0008","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1056\/NEJMra1309483","article-title":"Lactic acidosis","volume":"371","author":"Kraut","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mycmed.2022.101330_bib0009","doi-asserted-by":"crossref","first-page":"e533","DOI":"10.1093\/cid\/ciaa1239","article-title":"Empiric antibacterial therapy and community-onset bacterial coinfection in patients hospitalized with coronavirus disease 2019 (COVID-19): a multi-hospital cohort study","volume":"72","author":"Vaughn","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2022.101330_bib0010","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/s12879-017-2492-8","article-title":"Outcomes and prognostic factors of non-HIV patients with pneumocystis jirovecii pneumonia and pulmonary CMV co-infection: a retrospective cohort study","volume":"17","author":"Yu","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.mycmed.2022.101330_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106019","article-title":"Pneumocystis pneumonia after lung transplantation: a retrospective multicenter study","volume":"169","author":"Delbove","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.mycmed.2022.101330_bib0012","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4065\/71.1.5","article-title":"Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy","volume":"71","author":"Yale","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.mycmed.2022.101330_bib0013","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fcimb.2020.00224","article-title":"Epidemiology of Pneumocystis jirovecii pneumonia and (Non-)use of Prophylaxis","volume":"10","author":"Dunbar","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.mycmed.2022.101330_bib0014","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1378\/chest.08-2859","article-title":"Trends in hospitalizations for AIDS-associated Pneumocystis jirovecii pneumonia in the United States","volume":"136","author":"Kelley","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.mycmed.2022.101330_bib0015","first-page":"659","article-title":"Epidemiological and clinical characteristics of immunocompromised patients infected with Pneumocystis jirovecii in a twelve-year retrospective study from Norway","volume":"21","author":"Jung","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.mycmed.2022.101330_bib0016","doi-asserted-by":"crossref","first-page":"167","DOI":"10.15403\/jgld-854","article-title":"Clinical characteristics and risk factors for Pneumocystis Jirovecii pneumonia during immunosuppressive treatment in patients with ulcerative colitis: a retrospective study","volume":"29","author":"Kojima","year":"2020","journal-title":"J Gastrointest Liver Dis"},{"key":"10.1016\/j.mycmed.2022.101330_bib0017","doi-asserted-by":"crossref","unstructured":"Lee EH, Kim EY, Lee SH, Roh YH, Leem AY, Song JH, et al. Risk factors and clinical characteristics of Pneumocystis jirovecii pneumonia in lung cancer. 2019; 9:2094","DOI":"10.1038\/s41598-019-38618-3"},{"key":"10.1016\/j.mycmed.2022.101330_bib0018","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000487713","article-title":"Clinical, diagnostic, and treatment disparities between HIV-infected and non-HIV-infected immunocompromised patients with Pneumocystis jirovecii pneumonia","volume":"96","author":"Salzer","year":"2018","journal-title":"Respiration"},{"key":"10.1016\/j.mycmed.2022.101330_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106492","article-title":"Fungal pneumonia in kidney transplant recipients","volume":"185","author":"Wilmes","year":"2021","journal-title":"Respir Med"},{"key":"10.1016\/j.mycmed.2022.101330_bib0020","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/14787210.2017.1305887","article-title":"Diagnosis and management of Pneumocystis jirovecii infection","volume":"15","author":"White","year":"2017","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.mycmed.2022.101330_bib0021","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-0039-3399559","article-title":"Pneumocystis jiroveci","volume":"41","author":"Fishman","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.mycmed.2022.101330_bib0022","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1093\/cid\/ciaa1786","article-title":"Defining galactomannan positivity in the updated EORTC\/MSGERC consensus definitions of invasive fungal diseases","volume":"72","author":"Mercier","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2022.101330_bib0023","article-title":"The clinical characteristics of patients with non-neutropenic invasive pulmonary aspergillosis","volume":"8","author":"Liu","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.mycmed.2022.101330_bib0024","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1146\/annurev-immunol-103019-085803","article-title":"Vivo CD4(+) T cell differentiation and function: revisiting the Th1\/Th2 paradigm","volume":"38","author":"Ruterbusch","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.mycmed.2022.101330_bib0025","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1086\/319866","article-title":"Survival of patients with AIDS, after diagnosis of Pneumocystis carinii pneumonia, in the United States","volume":"183","author":"Dworkin","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mycmed.2022.101330_bib0026","doi-asserted-by":"crossref","first-page":"e13877","DOI":"10.1111\/ctr.13877","article-title":"CD4(+) T cell lymphopenia predicts mortality from Pneumocystis pneumonia in kidney transplant patients","volume":"34","author":"Freiwald","year":"2020","journal-title":"Clin Transplant"},{"key":"10.1016\/j.mycmed.2022.101330_bib0027","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1378\/chest.108.2.415","article-title":"Serum lactate dehydrogenase (LDH) in Pneumocystis carinii pneumonia, tuberculosis, and bacterial pneumonia","volume":"108","author":"Quist","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.mycmed.2022.101330_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.850741","article-title":"A clinically applicable nomogram for predicting the risk of invasive mechanical ventilation in Pneumocystis jirovecii pneumonia","volume":"12","author":"Wan","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.mycmed.2022.101330_bib0029","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jiac.2020.12.017","article-title":"Blood urea nitrogen-to-serum albumin ratio and A-DROP are useful in assessing the severity of Pneumocystis pneumonia in patients without human immunodeficiency virus infection","volume":"27","author":"Akahane","year":"2021","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.mycmed.2022.101330_bib0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijid.2019.08.015","article-title":"High initial (1, 3) Beta-d-Glucan concentration may be a predictor of satisfactory response of c aspofungin combined with TMP\/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia","volume":"88","author":"Jin","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.mycmed.2022.101330_bib0031","article-title":"Risk factors of mortality from Pneumocystis pneumonia in non-HIV patients: a meta-analysis","volume":"9","author":"Wang","year":"2021","journal-title":"Front Public Health"}],"container-title":["Journal of Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523322000877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523322000877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:21:17Z","timestamp":1761110477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523322000877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1156523322000877"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2022.101330","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics and risk factors of in-hospital mortality in patients coinfected with Pneumocystis jirovecii and Aspergillus","name":"articletitle","label":"Article Title"},{"value":"Journal of Medical Mycology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2022.101330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS on behalf of SFMM.","name":"copyright","label":"Copyright"}],"article-number":"101330"}}